Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Apple Faces Stiff Competition in China as Huawei Surges

by Global Market Bulletin
October 16, 2023
in Stock Market News
0
Apple Faces Stiff Competition in China as Huawei Surges
99
SHARES
216
VIEWS
Share on FacebookShare on Twitter

Apple (NASDAQ:AAPL) has been riding the wave of success with its iconic iPhone range for years. However, recent market trends indicate a potential challenge, especially in China. Data shows that the tech giant’s latest offering, the iPhone 15, hasn’t been as warmly received in the Chinese market as anticipated.

You might also like

Here’s Why You Must Seriously Include Humacyte (HUMA) in Your Watchlist

Should You Now Try to Invest in Allogene Therapeutics (ALLO)?

Is Aardvark Therapeutics (AARD) a Smart Long-Term Buy?

Based on figures from Counterpoint Research, sales of the iPhone 15 have seen a 4.5% drop in the first 17 days after its launch when compared to its predecessor, the iPhone 14. This decline had a notable impact on Apple’s stock, which dipped by 1.2% following the revelation.

What’s even more concerning for the Cupertino-based tech giant is the perspective shared by analysts at Jefferies. They posit that the sales dip might be more pronounced, estimating a potential double-digit percentage decline against the iPhone 14.

Apple’s softening grip on the Chinese market could be attributed to several factors. China’s economic woes may be part of the reason, but it’s impossible to overlook the meteoric rise of domestic competitors like Huawei. In fact, the latest projections from Counterpoint suggest that Huawei’s Mate 60 Pro could see sales ranging between 5 to 6 million units this year alone. With a trajectory like this, it’s plausible that Huawei’s figures could touch the double-digit million mark by 2024.

This rapid growth has already yielded significant outcomes. Huawei has successfully managed to eclipse Apple, securing the top position in the market, as highlighted in a note by Jefferies. If these trends persist, the analysts foresee a scenario where Apple might find itself in Huawei’s shadow by 2024.

Furthermore, Jefferies analysts caution about the ripple effect of this decline. If Apple’s demand continues to wane in China, this could influence a worldwide decline in iPhone shipments.

In conclusion, while Apple has been a dominant force in the tech world, it’s crucial for them to recalibrate their strategies in China. With homegrown companies like Huawei aggressively expanding their market share, Apple’s journey ahead in the Chinese market is set to be an uphill battle.

Tags: Apple Stock - AAPL
Share40Tweet25

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Here’s Why You Must Seriously Include Humacyte (HUMA) in Your Watchlist

by Global Market Bulletin
March 29, 2026
0
Here’s Why You Must Seriously Include Humacyte (HUMA) in Your Watchlist

We recently published our articleTop 5 Penny Stocks That Could Turn $1,000 Into $1 Million. To read the full article, head on to Top 10 Penny Stocks That...

Read moreDetails

Should You Now Try to Invest in Allogene Therapeutics (ALLO)?

by Global Market Bulletin
March 29, 2026
0
Should You Now Try to Invest in Allogene Therapeutics (ALLO)?

We recently published our articleTop 5 Penny Stocks That Could Turn $1,000 Into $1 Million. To read the full article, head on to Top 10 Penny Stocks That...

Read moreDetails

Is Aardvark Therapeutics (AARD) a Smart Long-Term Buy?

by Global Market Bulletin
March 29, 2026
0
Is Aardvark Therapeutics (AARD) a Smart Long-Term Buy?

We recently published our articleTop 5 Penny Stocks That Could Turn $1,000 Into $1 Million. To read the full article, head on to Top 10 Penny Stocks That...

Read moreDetails

Is it a Wise Choice to Buy Agilon Health (AGL) Shares?

by Global Market Bulletin
March 29, 2026
0
Is it a Wise Choice to Buy Agilon Health (AGL) Shares?

We recently published our articleTop 5 Penny Stocks That Could Turn $1,000 Into $1 Million. To read the full article, head on to Top 10 Penny Stocks That...

Read moreDetails

Is it a Wise Move to Acquire Rezolve AI (RZLV) Shares?

by Global Market Bulletin
March 29, 2026
0
Is it a Wise Move to Acquire Rezolve AI (RZLV) Shares?

We recently published our article Top 5 Penny Stocks That Could Turn $1,000 Into $1 Million. To read the full article, head on to Top 10 Penny Stocks...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Here’s Why You Must Seriously Include Humacyte (HUMA) in Your Watchlist
  • Should You Now Try to Invest in Allogene Therapeutics (ALLO)?
  • Is Aardvark Therapeutics (AARD) a Smart Long-Term Buy?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?